Skip to main content

Table 4 Mean clinical chemistry parameters for 28 week repeated oral doses of E. kebericho decoction treated rats

From: Acute and sub-acute toxicity of Echinops kebericho decoction in rats

Parameter

Male

Female

P-value

control

150 mg/kg

300 mg/kg

600 mg/kg

Control

150 mg/kg

300 mg/kg

600 mg/kg

 

AST (U/L)

260.2 ± 30.06

288.3 ± 70.71

241.6 ± 76.59

173.5 ± 21.89

304.2 ± 256.1

190.6 ± 20.74

193.6 ± 29.08

301.6 ± 309.4

0.0559 /0.1173

ALT (U/L)

84.20 ± 7.73

80.75 ± 6.99

88.00 ± 14.37

64.20 ± 6.30

123.0 ± 128.3

70.40 ± 4.88

56.60 ± 7.16

83.80 ± 22.11

0.0036 */0.6072

ALP (U/L)

74.60 ± 20.26

71.25 ± 23.91

106.6 ± 56.20

131.3 ± 16.88

197.8 ± 126.4

52.20 ± 16.98

45.40 ± 46.41

83.20 ± 32.82

0.0162 */0.0577

Creatinine (mg/dl)

0.60 ± 0.07

0.52 ± 0.10

0.52 ± 0.16

0.30 ± 0.12

0.60 ± 0.07

0.52 ± 0.08

0.46 ± 0.05

0.42 ± 0.11

0.0077 */0.0005 **

Urea (mg/dL)

40.30 ± 2.94

42.00 ± 1.26

50.48 ± 6.58

41.50 ± 3.90

47.22 ± 6.14

48.30 ± 7.97

42.72 ± 5.02

43.88 ± 3.51

0.1288/0.5085

Protein total (g/dl)

5.90 ± 0.73

6.30 ± 0.74

6.32 ± 1.00

5.80 ± 0.63

7.06 ± 0.56

6.60 ± 1.40

6.48 ± 0.58

6.62 ± 0.43

0.1531 /0.9694

Albumin (g/dl)

3.20 ± 0.12

3.22 ± 0.17

3.14 ± 0.21

3.05 ± 0.10

3.56 ± 0.24

3.36 ± 0.15

3.38 ± 0.22

3.42 ± 0.228

0.0122*/0.6266

Glucose (mg/dl)

127.4 ± 42.51

178.8 ± 69.63

181.6 ± 64.31

124.8 ± 33.04

116.2 ± 17.71

193.0 ± 45.67

140.0 ± 31.16

188.6 ± 62.42

0.0457*/0.0581

Bil-total (mg/dl)

0.18 ± 0.04

0.38 ± 0.15

0.20 ± 0.0

0.28 ± 0.10

0.26 ± 0.05

0.16 ± 0.05

0.24 ± 0.09

0.34 ± 0.05

0.0036*/0.0644

Bil-direct (mg/dl)

0.10 ± 0.0

0.32 ± 0.10

0.14 ± 0.06

0.12 ± 0.05

0.14 ± 0.06

0.20 ± 0.07

0.14 ± 0.06

0.22 ± 0.11

0.0129*/0.0065**

TG (mg/dl)

79.40 ± 20.19

79.50 ± 8.96

66.60 ± 20.19

51.25 ± 13.45

98.00 ± 41.43

75.20 ± 14.45

58.00 ± 17.56

62.00 ± 9.38

0.0338*/0.0042**

Cholesterol (mg/dl)

33.60 ± 10.85

79.50 ± 16.76

65.60 ± 15.63

38.50 ± 3.70

84.60 ± 37.63

81.80 ± 29.78

81.20 ± 18.10

80.60 ± 12.52

0.0013*/0.2970

  1. *Significant p-value when males and females are treated separately, **Significant p-value when males and females are grouped together: Where, ALP Alkaline phosphatase, ALT Alanine aminotransferase, AST Aspartate Aminotransferase, TG Triglycerides, Bil-total Bilirubin Total, Bil-direct Direct Bilirubin3.2.3. Post-hoc analysis result